Skip to main content

Table 3 Univariate and multivariate analysis of disease-free survival

From: Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

  Univariant analysis p-value Multivariant analysis p-value
HR (95% CI) HR (95% CI)
Gender:male/female 0.77 (0.37–1.59) NS   
Child-Pugh score: A/B 0.94 (0.32–1.61) NS   
HBV DNA ≤ 4 (log copies/mL) 0.71 (0.33–1.54) NS   
HBeAg: negative/positive 0.61 (0.11–0.91) < 0.05   
Non-cirrhosis/Cirrhosis 0.47 (0.21–0.98) < 0.05 0.41 (0.13–0.77) < 0.05
Total bilirubin: <  24/≥ 24 (μmol/L) 1.15 (0.69–1.91) NS   
TDF treatment/ETV treatment 0.78 (0.43–0.97) < 0.05 0.35 (0.33–0.84) < 0.05
  1. AFP = α-fetoprotein; HBeAg = hepatitis B e antigen; HBV = hepatitis B virus